Tangiers to re-list on ASX following two week suspension


Published 28-APR-2014 15:23 P.M.


2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

Tangiers Petroleum Ltd (ASX: TPT) is planning to re-list on the ASX on the 9th of May, after it suspended its ASX trading for nearly two weeks.

Suspension on the ASX

The company announced on the 28th of April it was suspending its listing on the ASX after two key members of the company’s management team quit in the wake of a failed takeover.

Eve Howell, TPT Executive Chairperson, and Max de Vietri, TPT Non-Executive Director, resigned following TPT’s unsuccessful bid to acquire Jacka Resources (ASX:JKA). Both said they decided it was best to leave the company because they had ‘lost the support of several major shareholders’.

The decision to suspend ASX trading came while TPT began planning to spud three wells its offshore Moroccan development in North Africa.

New board members hired

Since the suspension, three new employees have been hired, including Managing Director David Wall, and TPT Directors Dr Stephen Staley and Michael Evans.

All three have vast experience in working with oil and gas companies, with Wall’s background strong in Africa and Dr Staley holding a PhD in Petroleum Geology. Evans was the former Executive Chairman of oil and gas explorer FAR which also has developments in Africa.

As activity builds ahead of the company’s spudding in mid-June, TPT has announced that it would like to re-list on the ASX on or before the 9th of May, so that it can have a chance at raising further funds for its Moroccan offshore development.

TAO-1 well on the Jurassic carbonate fairway

TPT is planning to drill at its TAO-1 well, located on the Jurassic carbonate fairway in offshore Morocco. The area is proven to have oil potential, as previous tests of the area have shown overlying Cretaceous sediment and an absence of salt in the area, meaning it’s unlikely the drill results will produce heavy oil.

TPT is working with energy operator Galp in a farm-out, and the operator will be covering US$33M of TPT’s costs under the deal.

General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free